Xenetic Biosciences Inc.
XBIO | NASDAQ
$2.47
-$0.52 (-17.39%)
Sep 22, 2026, 2:34 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -2.48M | -2.23M | -2.68M | -3.16M | -3.08M | -3.67M | -3.96M | -4.08M | -4.7M | -4.47M | -4.13M | -4.45M | -4.19M | -5.82M | -6.55M | -6.91M | -7.46M | -5.89M | -5.65M | -5M | -11.21M | -11.06M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7.96K | 17.57K | 27.04K | 36.33K | 37.41K | 36.54K | 35.48K | 34.24K | 31.48K | 29.84K |
Stock-Based Compensation | 77.27K | 29.68K | 48.93K | 60.04K | 87.58K | 113.99K | 171.81K | 221.28K | 264.01K | 291.31K | 283.09K | 327.16K | 394.26K | 460.74K | 511.48K | 505.93K | 479.7K | 453.75K | 410.44K | 378.12K | 377.79K | 379.6K |
Other Working Capital | 93.64K | 65.81K | 255.66K | 260.08K | 1.16M | 942.85K | 886.31K | 978.55K | 288.73K | 150.58K | 845 | -460.04K | -490.76K | 88.63K | -78.74K | -219.68K | 14.58K | -151.53K | 4.06K | 95.68K | 159.14K | 302.38K |
Other Non-Cash Items | -73.21K | 27.17K | 15.85K | 15.85K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 488.75K | 870.35K | 2.18M | 2.18M | 1.69M | 1.31M | n/a | n/a | 2.92M | 6.32M | 6.18M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -381.6K | -381.6K | -381.6K | -381.6K | n/a | n/a | n/a | -2.92M | n/a | n/a |
Change in Working Capital | 158.23K | 356.12K | 329.42K | 362.45K | 476.71K | 894.29K | 970.98K | 919.46K | 1.01M | 10.7K | -262.73K | -442.4K | -898.63K | -118.27K | -426.69K | -290.31K | 327.59K | 95.98K | 461.19K | 358.14K | 267.41K | -316.09K |
Operating Cash Flow | -2.31M | -1.82M | -2.29M | -2.72M | -2.52M | -2.66M | -2.82M | -2.94M | -3.43M | -4.17M | -4.11M | -4.07M | -4.2M | -3.66M | -4.65M | -5.35M | -5.31M | -5.31M | -4.74M | -4.23M | -4.21M | -4.79M |
Capital Expenditures | -3 | -6 | -1 | -1 | 2 | 2 | n/a | n/a | 4 | 4 | 2 | 2 | -2 | -3 | -1 | -2 | -2 | -1 | -3 | -2 | -2 | -2 |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -500K | -500K | -500K | -500K | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -500K | -500K | -500K | -500K | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | 4M | 4M | 4M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 11.45M | 11.45M | 11.45M | 16.88M | 5.43M | 5.43M |
Net Cash Flow | 1.69M | 2.18M | 1.72M | -2.72M | -2.52M | -2.66M | -2.82M | -2.94M | -3.43M | -4.17M | -4.11M | -4.07M | -4.2M | -4.16M | -5.15M | -5.85M | 5.65M | 6.15M | 6.72M | 12.65M | 1.22M | 641.16K |
Free Cash Flow | -2.31M | -1.82M | -2.29M | -2.72M | -2.52M | -2.66M | -2.82M | -2.94M | -3.43M | -4.17M | -4.11M | -4.07M | -4.2M | -3.66M | -4.65M | -5.35M | -5.31M | -5.31M | -4.74M | -4.23M | -4.21M | -4.79M |
Adj. Free Cash Flow | -2.39M | -1.85M | -2.34M | -2.78M | -2.61M | -2.77M | -2.99M | -3.16M | -3.69M | -4.46M | -4.4M | -4.4M | -4.6M | -4.12M | -5.16M | -5.86M | -5.79M | -5.76M | -5.15M | -4.61M | -4.59M | -5.17M |
Maintenance CapEx | n/a | n/a | 4 | 4 | 4 | 4 | n/a | n/a | 8 | 8 | 8 | 8 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Growth CapEx | -3 | -6 | -5 | -5 | -2 | -2 | n/a | n/a | -4 | -4 | -6 | -6 | -2 | -3 | -1 | -2 | -2 | -1 | -3 | -2 | -2 | -2 |
Owner Earnings | -2.31M | -1.82M | -2.29M | -2.72M | -2.52M | -2.66M | -2.82M | -2.94M | -3.43M | -4.17M | -4.11M | -4.07M | -4.2M | -3.66M | -4.65M | -5.35M | -5.31M | -5.31M | -4.74M | -4.23M | -4.21M | -4.79M |
Add to Watchlist
Select watchlists to add or remove XBIO